Low serum carnitine in HIV-infected children on antiretroviral treatment
- 24 September 2003
- journal article
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 57 (10) , 1317-1322
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Muscle carnitine deficiency associated with zidovudine‐induced mitochondrial myopathyAnnals of Neurology, 1994
- Carnitine depletion in peripheral blood mononuclear cells from patients with AIDSAIDS, 1994
- Zidovudine‐induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storageAnnals of Neurology, 1994
- High Dose L-Carnitine Improves Immunologic and Metabolic Parameters in Aids PatientsImmunopharmacology and Immunotoxicology, 1993
- Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathyThe Lancet, 1991
- Micronutrient Status and Human Immunodeficiency Virus (HIV) InfectionAnnals of the New York Academy of Sciences, 1990
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990